UBS Maintains Neutral on Universal Health Servs, Raises Price Target to $177
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Andrew Mok maintains a Neutral rating on Universal Health Services (UHS) and raises the price target from $152 to $177.
February 29, 2024 | 12:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS has maintained a Neutral rating on Universal Health Services and increased the price target from $152 to $177.
The increase in price target by UBS suggests a positive outlook on the stock's future performance, potentially leading to short-term price appreciation. However, the Neutral rating indicates that the stock might not outperform the market significantly.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 90